WHO ICTRP trial
Effects of Korodin? Herz-Kreislauf-Tropfen on low blood pressure and cognitive…
EUCTR2012-005810-21-DE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-005810-21-DE |
|---|---|
| Public title | Effects of Korodin? Herz-Kreislauf-Tropfen on low blood pressure and cognitive functions in adolescents |
| Scientific title | Effects of Korodin? Herz-Kreislauf-Tropfen on low blood pressure and cognitive functions in adolescents |
| Primary sponsor | Robugen GmbH |
| Secondary sponsors | Robugen GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Interventions | Trade Name: Korodin® Herz-Kreislauf-Tropfen Pharmaceutical Form: Oral drops, liquid INN or Proposed INN: D-Camphor Other descriptive name: D-CAMPHOR Concentration unit: g gram(s) Concentration number: 2,5- INN or Proposed INN: Hawthorn… |
| Registration date | Mar 24, 2014 |
| Target size | 100 |
| Secondary IDs | 012013 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: